CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.

by David Kremer, Qiao-Ling Cui, Peter Göttle, Tanja Kuhlmann, Hans-Peter Hartung, Jack Antel, Patrick Küry
Published 2016-01-01

Cerebrospinal fluid biomarkers in multiple sclerosis

by Hayrettin Tumani, Hans-Peter Hartung, Bernhard Hemmer, Charlotte Teunissen, Florian Deisenhammer, Gavin Giovannoni, Uwe K. Zettl
Published 2009-08-01

Neuroprotective Properties of Dimethyl Fumarate Measured by Optical Coherence Tomography in Non-inflammatory Animal Models

by Michael Dietrich, Christina Hecker, Milad Nasiri, Sogol Samsam, Andrea Issberner, Zippora Kohne, Hans-Peter Hartung, Philipp Albrecht
Published 2021-01-01

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.

by Christoph Buerth, Anne K Mausberg, Maximilian K Heininger, Hans-Peter Hartung, Bernd C Kieseier, Joachim F Ernst
Published 2016-01-01

Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke.

by John-Ih Lee, Michael Gliem, Gebke Gerdes, Bernd Turowski, Marius Kaschner, Bastian Kraus, Hans-Peter Hartung, Sebastian Jander
Published 2017-01-01

Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years – case report

by Tobias Wienemann, Ann-Kristin Müller, Colin MacKenzie, Carina Bielor, Vivien Weyers, Orhan Aktas, Hans-Peter Hartung, David Kremer
Published 2020-04-01

Review of teriflunomide and its potential in the treatment of multiple sclerosis

by Clemens Warnke, Gerd Meyer zu Hörste, Hans-Peter Hartung, Olaf Stüve, et al.
Published 2009-05-01

No Alteration of Optical Coherence Tomography and Multifocal Visual Evoked Potentials in Eyes With Symptomatic Carotid Artery Disease

by John-Ih Lee, Lena Gemerzki, Laura Boerker, Rainer Guthoff, Orhan Aktas, Michael Gliem, Sebastian Jander, Hans-Peter Hartung, Philipp Albrecht
Published 2019-07-01

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate...

by Johannes Ehler, Stephan Blechinger, Paulus S. Rommer, Sebastian Koball, Steffen Mitzner, Hans-Peter Hartung, Fritz Leutmezer, Martin Sauer, Uwe K. Zettl
Published 2017-08-01

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets

by Ralf Gold, Gerd Fätkenheuer, Hans-Peter Hartung, Christoph Kleinschnitz, Reinhard Marks, Matthias Maschke, Antonios Bayas, Micha Löbermann, Uwe K. Zettl, Heinz Wiendl
Published 2021-07-01

Retinal Changes After Posterior Cerebral Artery Infarctions Display Different Patterns of the Nasal und Temporal Sector in a Case Series

by John-Ih Lee, Laura Boerker, Lena Gemerzki, Jens Harmel, Rainer Guthoff, Orhan Aktas, Michael Gliem, Sebastian Jander, Hans-Peter Hartung, Philipp Albrecht
Published 2020-06-01

Retinal neurodegeneration in Wilson's disease revealed by spectral domain optical coherence tomography.

by Philipp Albrecht, Ann-Kristin Müller, Marius Ringelstein, David Finis, Gerd Geerling, Eva Cohn, Orhan Aktas, Hans-Peter Hartung, Harald Hefter, Axel Methner
Published 2012-01-01

Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers

by Oliver Neuhaus, Wolfgang Köhler, Florian Then Bergh, Wolfgang Kristoferitsch, Jürgen Faiss, Thorsten Rosenkranz, Dirk Reske, Robert Patejdl, Hans-Peter Hartung, Uwe K. Zettl
Published 2021-03-01

Correction: Promoting Myelination in an In Vitro Mouse Model of the Peripheral Nervous System: The Effect of Wine Ingredients

by Mark Stettner, Kathleen Wolffram, Anne K. Mausberg, Philipp Albrecht, Angelika Derksen, Axel Methner, Thomas Dehmel, Hans-Peter Hartung, Helmut Dietrich, Bernd C. Kieseier
Published 2013-01-01

Correction: Promoting Myelination in an Mouse Model of the Peripheral Nervous System: The Effect of Wine Ingredients.

by Mark Stettner, Kathleen Wolffram, Anne K. Mausberg, Philipp Albrecht, Angelika Derksen, Axel Methner, Thomas Dehmel, Hans-Peter Hartung, Helmut Dietrich, Bernd C. Kieseier
Published 2013-01-01

Clinical trials in multiple sclerosis: potential future trial designs

by Navid Manouchehri, Yinan Zhang, Amber Salter, Rehana Z. Hussain, Hans-Peter Hartung, Bernhard Hemmer, Ralf Linker, Benjamin M. Segal, Gary Cutter, Olaf Stüve
Published 2019-05-01

Promoting myelination in an in vitro mouse model of the peripheral nervous system: the effect of wine ingredients [corrected].

by Mark Stettner, Kathleen Wolffram, Anne K Mausberg, Philipp Albrecht, Angelika Derksen, Axel Methner, Thomas Dehmel, Hans-Peter Hartung, Helmut Dietrich, Bernd C Kieseier
Published 2013-01-01

Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation.

by Janusz Joachim Jadasz, David Kremer, Peter Göttle, Nevena Tzekova, Julia Domke, Francisco J Rivera, James Adjaye, Hans-Peter Hartung, Ludwig Aigner, Patrick Küry
Published 2013-01-01

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis.

by Michael Hecker, Brigitte Katrin Paap, Robert Hermann Goertsches, Ole Kandulski, Christian Fatum, Dirk Koczan, Hans-Peter Hartung, Hans-Juergen Thiesen, Uwe Klaus Zettl
Published 2011-01-01

Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis.

by Gerd Meyer Zu Horste, Steffen Cordes, Johannes Pfaff, Christian Mathys, Anne K Mausberg, Martin Bendszus, Mirko Pham, Hans-Peter Hartung, Bernd C Kieseier
Published 2016-01-01